HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 64 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $816,000 | -7.8% | 68,000 | 0.0% | 0.25% | +0.4% |
| Q1 2023 | $885,360 | -11.7% | 68,000 | 0.0% | 0.25% | -20.3% |
| Q4 2022 | $1,003,000 | +66.6% | 68,000 | 0.0% | 0.31% | +60.6% |
| Q3 2022 | $602,000 | -99.1% | 68,000 | +7816.2% | 0.19% | -72.8% |
| Q2 2022 | $68,000,000 | +575.7% | 859 | -98.7% | 0.71% | -68.8% |
| Q1 2022 | $10,063,000 | +323.3% | 68,000 | 0.0% | 2.27% | +328.1% |
| Q4 2021 | $2,377,000 | -4.3% | 68,000 | 0.0% | 0.53% | -11.5% |
| Q3 2021 | $2,484,000 | -7.0% | 68,000 | 0.0% | 0.60% | -15.0% |
| Q2 2021 | $2,671,000 | – | 68,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 421,140 | $5,075,000 | 10.46% |
| Capital International, Inc./CA/ | 4,151,900 | $52,480,000 | 0.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 859 | $68,000,000 | 0.71% |
| GENERAL ATLANTIC, L.P. | 4,000,000 | $50,560,000 | 0.66% |
| Capital International Sarl | 544,653 | $6,884,000 | 0.55% |
| M&G INVESTMENT MANAGEMENT LTD | 6,977,228 | $90,704,000 | 0.54% |
| E Fund Management (Hong Kong) Co., Ltd. | 58,861 | $744,000 | 0.51% |
| Bellevue Group AG | 1,756,307 | $21,359,000 | 0.30% |
| AIA Group Ltd | 356,640 | $4,508,000 | 0.24% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 224,634 | $2,839,000 | 0.11% |